My career as an M.D./PhD. has combined clinical practice in medical oncology/oncohematology with translational research in cancer drug development. As the P.I. of an INSERM team for over 25 years, an investigator in several phase 1 to phase 3 clinical trials, a close collaborator with several pharmaceutical companies ranging from SME to big pharmas, and a founder of 3 start-ups, I have acquired the know-how and
built the network required to coordinate the multiple actors involved in the translation of a preclinical concept into an early phase clinical trial.